179 related articles for article (PubMed ID: 16455468)
1. Cyclooxygenase-2 expression and clinical outcome in gastrointestinal stromal tumors.
Stewart AE; Heslin MH; Arch J; Jhala N; Ragland B; Gomez F; Bland KI; Arnoletti JP
J Gastrointest Surg; 2006 Feb; 10(2):315-9. PubMed ID: 16455468
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
[TBL] [Abstract][Full Text] [Related]
4. [Gastrointestinal stromal tumor of the abdominal wall. An unusual localization of a rare tumor].
Thalheimer A; Meyer D; Gattenlöhner S; Timmermann W; Thiede A
Chirurg; 2004 Jul; 75(7):708-12. PubMed ID: 15257404
[TBL] [Abstract][Full Text] [Related]
5. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors.
Motegi A; Sakurai S; Nakayama H; Sano T; Oyama T; Nakajima T
Pathol Int; 2005 Mar; 55(3):106-12. PubMed ID: 15743318
[TBL] [Abstract][Full Text] [Related]
6. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
7. Does CD10 expression individuate a GIST subgroup of patients?
Caprino P; Pericoli Ridolfini M; Sofo L; Carbone A; Ricci R; Rosa F; Meloscia A; Doglietto GB
Minerva Chir; 2014 Oct; 69(5):271-6. PubMed ID: 24992324
[TBL] [Abstract][Full Text] [Related]
8. Expression of PIN1 in Gastrointestinal Stromal Tumours and its Clinical Significance.
Jiang L; Cao M; Hu J; Chen J
Anticancer Res; 2016 Mar; 36(3):1275-80. PubMed ID: 26977025
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and Prognostic Analysis of Primary Gastrointestinal Stromal Tumor Presenting with Gastrointestinal Bleeding: a 10-Year Retrospective Study.
Yin Z; Gao J; Liu W; Huang C; Shuai X; Wang G; Tao K; Zhang P
J Gastrointest Surg; 2017 May; 21(5):792-800. PubMed ID: 28275959
[TBL] [Abstract][Full Text] [Related]
11. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
12. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression and connection with tumor recurrence and histopathologic parameters in gastrointestinal stromal tumors.
Türköz HK; Alkan I; Sişman S; Ozcan D
APMIS; 2009 Nov; 117(11):825-30. PubMed ID: 19845533
[TBL] [Abstract][Full Text] [Related]
14. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
15. Histopathological features and clinical course of the gastrointestinal stromal tumors.
Di Matteo G; Pescarmona E; Peparini N; Di Matteo FM; Zeri KP; Mascagni D; Mele R; Maturo A; Redler A; De Antoni E
Hepatogastroenterology; 2002; 49(46):1013-6. PubMed ID: 12143190
[TBL] [Abstract][Full Text] [Related]
16. Study on Clinicopathological Features of Gastrointestinal Stromal Tumor and Relevant Prognostic Factors.
Liu Q; Wang Y; Kong L; Kan Y
Cell Biochem Biophys; 2015 Dec; 73(3):743-7. PubMed ID: 27259319
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal Stromal Tumors - Diagnosis and Surgical Treatment.
Alecu L; Tulin A; Enciu O; Bărbulescu M; Ursuţ B; Obrocea F
Chirurgia (Bucur); 2015; 110(6):525-9. PubMed ID: 26713826
[TBL] [Abstract][Full Text] [Related]
18. [Morphological characteristics and prognostic criteria for gastrointestinal stromal tumors].
Tsyganova IV; Anurova OA; Mazurenko NN
Arkh Patol; 2011; 73(6):37-42. PubMed ID: 22379899
[TBL] [Abstract][Full Text] [Related]
19. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
Jang BG; Lee HE; Kim WH
Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
[TBL] [Abstract][Full Text] [Related]
20. Clinical study on gastrointestinal stromal tumors (GIST) in Iceland, 1990-2003.
Tryggvason G; Kristmundsson T; Orvar K; Jónasson JG; Magnússon MK; Gíslason HG
Dig Dis Sci; 2007 Sep; 52(9):2249-53. PubMed ID: 17420941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
